STAT signaling in the pathogenesis and treatment of leukemias (Q33941357)

30 July 2017

1 reference

title

STAT signaling in the pathogenesis and treatment of leukemias (English)

1 reference

30 July 2017

0 references

Lin TS

1

1 reference

30 July 2017

Mahajan S

series ordinal

2

1 reference

30 July 2017

Frank DA

series ordinal

3

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 May 2000

1 reference

30 July 2017

1 reference

30 July 2017

19

1 reference

30 July 2017

21

1 reference

30 July 2017

2496-2504

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1203486

30 July 2017

0 references

cites work

SOCS1 is a critical inhibitor of interferon gamma signaling and prevents the potentially fatal neonatal actions of this cytokine.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203486

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203486

Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by Bcr/Abl

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203486

Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203486

Crystal structure of a tyrosine phosphorylated STAT-1 dimer bound to DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203486

STATs and gene regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203486

B lymphocytes from patients with chronic lymphocytic leukemia contain signal transducer and activator of transcription (STAT) 1 and STAT3 constitutively phosphorylated on serine residues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203486

Fludarabine-induced immunosuppression is associated with inhibition of STAT1 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203486

Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203486

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203486

STATs: signal transducers and activators of transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203486

P210 and P190(BCR/ABL) induce the tyrosine phosphorylation and DNA binding activity of multiple specific STAT family members

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203486

Jaks and STATs: biological implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203486

SOCS1 deficiency causes a lymphocyte-dependent perinatal lethality

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203486

Interferon-gamma-mediated activation of STAT1alpha regulates growth factor-induced mitogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203486

Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203486

Constitutively activated Jak-STAT pathway in T cells transformed with HTLV-I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203486

The very-long-term course of polycythaemia: a complement to the previously published data of the Polycythaemia Vera Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203486

Signal transducer and activator of transcription (STAT)5 activation by BCR/ABL is dependent on intact Src homology (SH)3 and SH2 domains of BCR/ABL and is required for leukemogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203486

21 January 2018

Chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203486

Interferon activation of the transcription factor Stat91 involves dimerization through SH2-phosphotyrosyl peptide interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203486

A single phosphotyrosine residue of Stat91 required for gene activation by interferon-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203486

Proliferation of adult T cell leukemia/lymphoma cells is associated with the constitutive activation of JAK/STAT proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203486

All-trans-retinoic acid in acute promyelocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203486

Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203486

Constitutive activation of different Jak tyrosine kinases in human T cell leukemia virus type 1 (HTLV-1) tax protein or virus-transformed cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203486

Activation of Jak/STAT proteins involved in signal transduction pathway mediated by receptor for interleukin 2 in malignant T lymphocytes derived from cutaneous anaplastic large T-cell lymphoma and Sezary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203486

Requirement of serine phosphorylation for formation of STAT-promoter complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203486

Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203486

7 January 2021

Activation of a Drosophila Janus kinase (JAK) causes hematopoietic neoplasia and developmental defects.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203486

7 January 2021

Variation in the clinical courses of adult T-cell leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203486

7 January 2021

An amino acid substitution in the Drosophila hopTum-l Jak kinase causes leukemia-like hematopoietic defects.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203486

7 January 2021

Chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203486

7 January 2021

The myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203486

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1203486

1 reference

Dimensions Publication ID

30 July 2017

0 references

1 reference